Target type: biologicalprocess
Any process that modulates the rate, frequency or extent of the catalysis of the hydrolysis of ester linkages within ribonucleic acid by creating internal breaks. [GOC:dph, GOC:tb]
Endoribonuclease activity, the process of cleaving RNA molecules, is tightly regulated to ensure proper gene expression and cellular function. This regulation occurs at multiple levels, involving various mechanisms:
1. **Transcriptional Control:** The expression of endoribonuclease genes themselves can be regulated, influencing the overall abundance of these enzymes. Transcription factors, specific DNA sequences, and signaling pathways can all impact the rate of transcription and translation.
2. **Post-Translational Modifications:** After synthesis, endoribonucleases can undergo modifications such as phosphorylation, acetylation, or ubiquitination. These modifications can alter their activity, stability, or localization within the cell.
3. **Protein-Protein Interactions:** Endoribonucleases often interact with other proteins, forming complexes that modulate their activity. These interactions can activate or inhibit the enzyme's function, influencing the specificity and efficiency of RNA cleavage.
4. **RNA Binding Proteins:** Specific RNA binding proteins can recognize and bind to target RNA molecules, either protecting them from endoribonuclease cleavage or directing the enzyme to specific cleavage sites.
5. **Cellular Localization:** The compartmentalization of endoribonucleases within the cell plays a critical role in their activity. Some enzymes reside in the nucleus, processing pre-messenger RNA, while others are localized to the cytoplasm, affecting mRNA stability and translation.
6. **Environmental Factors:** Environmental cues such as stress, nutrient availability, or changes in temperature can influence endoribonuclease activity. These stimuli can activate signaling pathways that ultimately regulate the enzyme's function.
7. **Feedback Mechanisms:** The products of endoribonuclease activity can also feedback to regulate the enzyme itself. Cleavage products can act as inhibitors or activators, creating a dynamic feedback loop that fine-tunes RNA processing.
In summary, the regulation of endoribonuclease activity is a complex process involving multiple layers of control. This ensures the precise and efficient processing of RNA molecules, vital for maintaining cellular homeostasis and responding to changing environmental conditions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Nucleophosmin | A nucleophosmin that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06748] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
imatinib | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor | |
pd 173955 | PD 173955: inhibits src family-selective tyrosine kinase; structure in first source | aryl sulfide; dichlorobenzene; methyl sulfide; pyridopyrimidine | tyrosine kinase inhibitor |
ellagic acid | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | |
bosutinib | 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile: a Src kinase inhibitor; structure in first source | aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor |
crizotinib | crizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. | 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
ceritinib | ceritinib : A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonyl)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer. ceritinib: an anaplastic lymphoma kinase inhibitor | aminopyrimidine; aromatic ether; organochlorine compound; piperidines; secondary amino compound; sulfone | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |